CD19 and glioblastoma: Regarding the Bc and Pc compartment, RRMS and glioblastoma patients shared an increase in CD19+CD20− DN Bc, CD21− DN memory Bc, and Pc as well as a reduction in activated TZB while CD24+/CD27+ Bregs were only reduced in glioblastoma patients compared to controls.